Fund Overview of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
-
₹858.9 CrAUM
-
₹23.87NAV
-
0.99%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 10.24% | NA | 6.12% |
| 6 Months | 7.72% | NA | 12.92% |
| 1 Year | 15.15% | 15.15% | 6.04% |
| 2 Years | 29.85% | 13.95% | 24.93% |
| 3 Years | 100.04% | 26.00% | 25.71% |
| 5 Years | 98.39% | 14.68% | 19.91% |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation
equities
97.65%other assets or cash equivalents
2.35%Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw is one Equity mutual fund offered by Aditya Birla Sun Life Mutual Fund. Launched on 10 Jul 2019, the fund aims Long term capital growth. investments in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. It manages assets worth ₹858.9 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.99%. Fund Manager Manager Education Fund Manager Manager EducationAbout Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
The portfolio allocation consists of 97.65% in equities, 2.35% in other assets or cash equivalents.Managed by Dhaval Shah, it has delivered a return of 15.15% in the last year, a total return since inception of 20.96%.
The latest dividend was declared on 20 Feb 2026 at 14.10% of face value.
For those looking to make informed investment decisions it is useful to explore best sip in india that align with financial planning needs.
Key Metrics of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
-
Standard Deviation15.94%
-
Sharpe Ratio1.02%
-
Alpha-0.16%
-
Beta0.96%
Fund Details
|
|
Top Performing Mutual Funds
More funds from Aditya Birla Sun Life Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth
|
₹859 | 9.75% | 10.24% | 7.72% | 15.15% | 26.00% |
|
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth
|
₹859 | 9.61% | 9.86% | 6.99% | 13.64% | 24.31% |
|
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw
|
₹859 | 9.61% | 9.86% | 6.99% | 13.64% | 24.31% |
|
Aditya Birla Sun Life Nifty Healthcare Etf-growth
|
₹73 | 9.50% | 9.06% | 5.33% | 13.02% | 24.76% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹537.83 | 23.62% | 13.57% | 15.00% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹603.39 | 24.73% | 14.59% | 16.03% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹116.14 | 23.62% | 13.57% | 15.00% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹165.14 | 24.73% | 14.59% | 16.03% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹41.50 | 28.38% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹45.01 | 29.48% | 17.51% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹24.21 | 28.38% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹27.18 | 29.48% | 17.51% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹457.42 | 26.27% | 15.91% | 12.80% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹528.09 | 27.60% | 17.14% | 14.05% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.42% | ₹115.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.34% | ₹113.96 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.47% | ₹112.83 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.47% | ₹106.43 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.89% | ₹104.66 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.38% | ₹99.17 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.60% | ₹98.24 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.60% | ₹98.24 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.17% | ₹92.64 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.17% | ₹92.64 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.78% | ₹66.43 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.70% | ₹65.24 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.70% | ₹65.24 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.31% | ₹63.69 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.34% | ₹63.01 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.59% | ₹62.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.59% | ₹62.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.30% | ₹62.30 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.14% | ₹59.82 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.28% | ₹59.12 Cr |
| Cipla Ltd | Healthcare | 6.73% | ₹58.62 Cr |
| Cipla Ltd | Healthcare | 6.76% | ₹57.75 Cr |
| Cipla Ltd | Healthcare | 6.83% | ₹56.69 Cr |
| Cipla Ltd | Healthcare | 6.83% | ₹56.69 Cr |
| Cipla Ltd | Healthcare | 6.68% | ₹56.61 Cr |
| Cipla Ltd | Healthcare | 6.68% | ₹56.61 Cr |
| Cipla Ltd | Healthcare | 6.08% | ₹50.95 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.58% | ₹46.31 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.58% | ₹46.31 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.19% | ₹45.24 Cr |
| Abbott India Ltd | Healthcare | 5.10% | ₹44.50 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.20% | ₹44.39 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.03% | ₹43.23 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.99% | ₹42.83 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.99% | ₹42.61 Cr |
| Lupin Ltd | Healthcare | 4.79% | ₹40.86 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.00% | ₹40.58 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.71% | ₹39.44 Cr |
| Abbott India Ltd | Healthcare | 4.56% | ₹38.90 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.78% | ₹38.79 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.53% | ₹38.71 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.56% | ₹38.63 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.56% | ₹38.63 Cr |
| Lupin Ltd | Healthcare | 4.55% | ₹38.53 Cr |
| Lupin Ltd | Healthcare | 4.55% | ₹38.53 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.40% | ₹38.33 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.47% | ₹38.12 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.42% | ₹37.99 Cr |
| Abbott India Ltd | Healthcare | 4.57% | ₹37.88 Cr |
| Abbott India Ltd | Healthcare | 4.57% | ₹37.88 Cr |
| Lupin Ltd | Healthcare | 4.34% | ₹37.85 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.51% | ₹37.76 Cr |
| Abbott India Ltd | Healthcare | 4.48% | ₹37.54 Cr |
| Lupin Ltd | Healthcare | 4.52% | ₹37.50 Cr |
| Lupin Ltd | Healthcare | 4.52% | ₹37.50 Cr |
| Abbott India Ltd | Healthcare | 4.43% | ₹37.50 Cr |
| Abbott India Ltd | Healthcare | 4.43% | ₹37.50 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.45% | ₹36.91 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.45% | ₹36.91 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.31% | ₹36.75 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.30% | ₹36.47 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.30% | ₹36.47 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.22% | ₹36.27 Cr |
| Lupin Ltd | Healthcare | 4.21% | ₹36.15 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.43% | ₹35.97 Cr |
| Lupin Ltd | Healthcare | 4.21% | ₹35.96 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.28% | ₹35.81 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.19% | ₹35.73 Cr |
| Abbott India Ltd | Healthcare | 4.39% | ₹35.65 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.17% | ₹35.59 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.08% | ₹35.58 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.16% | ₹35.54 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.11% | ₹35.26 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.33% | ₹35.17 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.07% | ₹34.70 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.11% | ₹34.46 Cr |
| Abbott India Ltd | Healthcare | 4.02% | ₹34.31 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.94% | ₹33.67 Cr |
| Lupin Ltd | Healthcare | 4.14% | ₹33.63 Cr |
| Abbott India Ltd | Healthcare | 3.90% | ₹33.52 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.99% | ₹33.38 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.88% | ₹33.11 Cr |
| Lupin Ltd | Healthcare | 3.94% | ₹32.95 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.72% | ₹32.45 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.99% | ₹32.39 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.96% | ₹32.15 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.75% | ₹32.00 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.76% | ₹31.88 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.76% | ₹31.88 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.73% | ₹31.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.75% | ₹31.12 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.75% | ₹31.12 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.55% | ₹30.92 Cr |
| Cipla Ltd | Healthcare | 3.59% | ₹30.62 Cr |
| Cipla Ltd | Healthcare | 3.70% | ₹30.07 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.49% | ₹30.02 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.55% | ₹29.48 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.55% | ₹29.48 Cr |
| Reverse Repo | Unspecified | 3.35% | ₹28.38 Cr |
| Reverse Repo | Unspecified | 3.35% | ₹28.38 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.30% | ₹28.36 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.30% | ₹27.99 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.30% | ₹27.99 Cr |
| Cipla Ltd | Healthcare | 3.24% | ₹27.80 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.22% | ₹26.71 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.22% | ₹26.71 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.06% | ₹26.64 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.20% | ₹26.02 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.03% | ₹25.87 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.96% | ₹25.82 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.97% | ₹25.20 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.97% | ₹25.20 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.93% | ₹25.19 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.95% | ₹25.14 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.87% | ₹25.06 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.86% | ₹24.94 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹24.50 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹24.50 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.90% | ₹24.25 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.90% | ₹24.10 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.90% | ₹24.10 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.89% | ₹23.98 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.89% | ₹23.98 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.83% | ₹23.98 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.83% | ₹23.98 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.80% | ₹23.71 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.80% | ₹23.71 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.77% | ₹23.44 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.77% | ₹23.44 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.74% | ₹22.75 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.74% | ₹22.75 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.65% | ₹22.64 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.65% | ₹22.61 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.64% | ₹22.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.63% | ₹21.36 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.46% | ₹20.87 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.46% | ₹20.87 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.36% | ₹20.61 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.41% | ₹19.99 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.41% | ₹19.99 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.33% | ₹19.92 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.45% | ₹19.89 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.31% | ₹19.76 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.28% | ₹19.45 Cr |
| Shilpa Medicare Ltd | Healthcare | 2.26% | ₹19.43 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.28% | ₹19.31 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.28% | ₹19.31 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.28% | ₹19.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.28% | ₹19.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.30% | ₹19.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.29% | ₹19.01 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.29% | ₹19.01 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.16% | ₹18.79 Cr |
| Shilpa Medicare Ltd | Healthcare | 2.20% | ₹18.75 Cr |
| Reverse Repo | Unspecified | 2.18% | ₹18.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.16% | ₹18.57 Cr |
| Corona Remedies Ltd. | 2.17% | ₹18.57 Cr | |
| Sai Life Sciences Ltd. | Healthcare | 2.16% | ₹18.47 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.19% | ₹18.31 Cr |
| Corona Remedies Ltd. | 2.12% | ₹18.20 Cr | |
| Reverse Repo | Unspecified | 2.24% | ₹18.17 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 2.08% | ₹18.12 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.09% | ₹17.98 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.19% | ₹17.76 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.02% | ₹17.63 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.06% | ₹17.58 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.07% | ₹17.52 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.07% | ₹17.52 Cr |
| Corona Remedies Ltd. | 2.13% | ₹17.30 Cr | |
| Divi's Laboratories Ltd | Healthcare | 1.97% | ₹17.15 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.00% | ₹16.99 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.00% | ₹16.99 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.97% | ₹16.89 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.97% | ₹16.84 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.96% | ₹16.84 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.97% | ₹16.81 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.01% | ₹16.80 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 2.01% | ₹16.70 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 2.01% | ₹16.70 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.95% | ₹16.66 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.96% | ₹16.63 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.96% | ₹16.63 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.98% | ₹16.62 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.94% | ₹16.58 Cr |
| Reverse Repo | Unspecified | 1.89% | ₹16.46 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.92% | ₹16.36 Cr |
| Corona Remedies Ltd. | 1.93% | ₹16.20 Cr | |
| Shilpa Medicare Ltd | Healthcare | 1.98% | ₹16.09 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.93% | ₹16.04 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.93% | ₹16.04 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.92% | ₹15.92 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.92% | ₹15.92 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.82% | ₹15.90 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.89% | ₹15.80 Cr |
| Reverse Repo | Unspecified | 1.90% | ₹15.78 Cr |
| Reverse Repo | Unspecified | 1.90% | ₹15.78 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.94% | ₹15.73 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.87% | ₹15.64 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.80% | ₹15.46 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.90% | ₹15.45 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.78% | ₹15.07 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.78% | ₹15.07 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.83% | ₹14.89 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.76% | ₹14.89 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.76% | ₹14.89 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.78% | ₹14.79 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.78% | ₹14.79 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.71% | ₹14.58 Cr |
| Reverse Repo | Unspecified | 1.68% | ₹14.32 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.63% | ₹13.96 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.60% | ₹13.93 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.65% | ₹13.67 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.65% | ₹13.67 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.64% | ₹13.64 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.64% | ₹13.64 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.63% | ₹13.63 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.58% | ₹13.56 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.54% | ₹13.40 Cr |
| Reverse Repo | Unspecified | 1.57% | ₹13.39 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.56% | ₹13.23 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.56% | ₹13.23 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.55% | ₹13.10 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.55% | ₹13.10 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.52% | ₹12.97 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.49% | ₹12.97 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.55% | ₹12.95 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.50% | ₹12.79 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.49% | ₹12.73 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.55% | ₹12.61 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.50% | ₹12.58 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.55% | ₹12.58 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.44% | ₹12.57 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.46% | ₹12.50 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.46% | ₹12.46 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.46% | ₹12.42 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.45% | ₹12.42 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.44% | ₹12.39 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.46% | ₹12.11 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.46% | ₹12.11 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹12.06 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.48% | ₹12.06 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.43% | ₹12.02 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.44% | ₹11.98 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.44% | ₹11.98 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.40% | ₹11.85 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.40% | ₹11.85 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.38% | ₹11.72 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.38% | ₹11.72 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.36% | ₹11.66 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.41% | ₹11.48 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.34% | ₹11.45 Cr |
| Reverse Repo | Unspecified | 1.36% | ₹11.39 Cr |
| Sanofi India Ltd | Healthcare | 1.29% | ₹11.24 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.29% | ₹11.20 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.31% | ₹10.90 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.31% | ₹10.90 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.27% | ₹10.87 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.29% | ₹10.84 Cr |
| Biocon Ltd | Healthcare | 1.27% | ₹10.82 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.27% | ₹10.74 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.27% | ₹10.74 Cr |
| Biocon Ltd | Healthcare | 1.28% | ₹10.70 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.24% | ₹10.68 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.26% | ₹10.64 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.26% | ₹10.64 Cr |
| Biocon Ltd | Healthcare | 1.22% | ₹10.63 Cr |
| Biocon Ltd | Healthcare | 1.24% | ₹10.59 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.24% | ₹10.57 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.23% | ₹10.53 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.23% | ₹10.45 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.23% | ₹10.45 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.28% | ₹10.43 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.21% | ₹10.34 Cr |
| Gland Pharma Ltd | Healthcare | 1.18% | ₹10.32 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.23% | ₹10.24 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.23% | ₹10.24 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.22% | ₹10.18 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.19% | ₹10.13 Cr |
| Biocon Ltd | Healthcare | 1.19% | ₹10.11 Cr |
| Biocon Ltd | Healthcare | 1.19% | ₹10.11 Cr |
| Procter & Gamble Health Ltd | Healthcare | 1.24% | ₹10.08 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.16% | ₹10.07 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.20% | ₹9.99 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.20% | ₹9.99 Cr |
| Biocon Ltd | Healthcare | 1.23% | ₹9.96 Cr |
| Gland Pharma Ltd | Healthcare | 1.20% | ₹9.96 Cr |
| Gland Pharma Ltd | Healthcare | 1.20% | ₹9.96 Cr |
| Biocon Ltd | Healthcare | 1.14% | ₹9.80 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.15% | ₹9.80 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.14% | ₹9.69 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.11% | ₹9.66 Cr |
| Gland Pharma Ltd | Healthcare | 1.14% | ₹9.64 Cr |
| Gland Pharma Ltd | Healthcare | 1.14% | ₹9.64 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.11% | ₹9.54 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.08% | ₹9.30 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.09% | ₹9.28 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.09% | ₹9.28 Cr |
| Biocon Ltd | Healthcare | 1.12% | ₹9.26 Cr |
| Biocon Ltd | Healthcare | 1.12% | ₹9.26 Cr |
| Gland Pharma Ltd | Healthcare | 1.14% | ₹9.23 Cr |
| Pfizer Ltd | Healthcare | 1.08% | ₹9.19 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.05% | ₹9.16 Cr |
| Gland Pharma Ltd | Healthcare | 1.07% | ₹9.11 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.06% | ₹9.09 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.12% | ₹9.08 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.09% | ₹9.04 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.09% | ₹9.04 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.08% | ₹9.03 Cr |
| Piramal Pharma Ltd | Healthcare | 1.06% | ₹9.02 Cr |
| Piramal Pharma Ltd | Healthcare | 1.10% | ₹8.94 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.05% | ₹8.92 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.10% | ₹8.90 Cr |
| Gland Pharma Ltd | Healthcare | 1.03% | ₹8.80 Cr |
| Piramal Pharma Ltd | Healthcare | 1.04% | ₹8.78 Cr |
| Piramal Pharma Ltd | Healthcare | 1.04% | ₹8.78 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.00% | ₹8.72 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.03% | ₹8.66 Cr |
| Gland Pharma Ltd | Healthcare | 1.03% | ₹8.61 Cr |
| Pfizer Ltd | Healthcare | 1.01% | ₹8.59 Cr |
| Pfizer Ltd | Healthcare | 1.01% | ₹8.59 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.03% | ₹8.55 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.03% | ₹8.55 Cr |
| Gland Pharma Ltd | Healthcare | 0.99% | ₹8.48 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.99% | ₹8.43 Cr |
| Piramal Pharma Ltd | Healthcare | 1.01% | ₹8.41 Cr |
| Piramal Pharma Ltd | Healthcare | 1.01% | ₹8.41 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.96% | ₹8.41 Cr |
| Pfizer Ltd | Healthcare | 1.00% | ₹8.31 Cr |
| Pfizer Ltd | Healthcare | 1.00% | ₹8.31 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.99% | ₹8.30 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.95% | ₹8.29 Cr |
| Pfizer Ltd | Healthcare | 1.02% | ₹8.28 Cr |
| Piramal Pharma Ltd | Healthcare | 0.96% | ₹8.24 Cr |
| Pfizer Ltd | Healthcare | 0.98% | ₹8.23 Cr |
| Pfizer Ltd | Healthcare | 0.96% | ₹8.21 Cr |
| Vinati Organics Ltd | Materials | 0.99% | ₹8.20 Cr |
| Vinati Organics Ltd | Materials | 0.99% | ₹8.20 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.95% | ₹8.14 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.97% | ₹8.11 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.95% | ₹8.03 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.95% | ₹8.03 Cr |
| Piramal Pharma Ltd | Healthcare | 0.92% | ₹7.89 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.97% | ₹7.88 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.92% | ₹7.86 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.94% | ₹7.82 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.94% | ₹7.82 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.91% | ₹7.81 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.94% | ₹7.80 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.94% | ₹7.80 Cr |
| Vinati Organics Ltd | Materials | 0.92% | ₹7.80 Cr |
| Vinati Organics Ltd | Materials | 0.92% | ₹7.80 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 0.90% | ₹7.76 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.91% | ₹7.73 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.91% | ₹7.73 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.90% | ₹7.64 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 0.89% | ₹7.63 Cr |
| Piramal Pharma Ltd | Healthcare | 0.90% | ₹7.58 Cr |
| Vinati Organics Ltd | Materials | 0.90% | ₹7.50 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.92% | ₹7.50 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.87% | ₹7.49 Cr |
| Vinati Organics Ltd | Materials | 0.87% | ₹7.46 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.87% | ₹7.32 Cr |
| Vinati Organics Ltd | Materials | 0.89% | ₹7.21 Cr |
| Vinati Organics Ltd | Materials | 0.82% | ₹7.13 Cr |
| Vinati Organics Ltd | Materials | 0.81% | ₹6.95 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.78% | ₹6.74 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.78% | ₹6.74 Cr |
| Max Healthcare Institute Ltd | Healthcare | 0.82% | ₹6.70 Cr |
| Vinati Organics Ltd | Materials | 0.73% | ₹6.25 Cr |
| Net Receivables | Unspecified | 0.65% | ₹5.57 Cr |
| Net Receivables | Unspecified | 0.17% | ₹1.48 Cr |
| Net Receivables | Unspecified | 0.06% | ₹0.52 Cr |
| Net Payables | Unspecified | -0.01% | ₹-0.11 Cr |
| Net Payables | Unspecified | -0.09% | ₹-0.79 Cr |
| Net Payables | Unspecified | -0.09% | ₹-0.79 Cr |
| Net Payables | Unspecified | -0.17% | ₹-1.39 Cr |
| Net Payables | Unspecified | -0.21% | ₹-1.73 Cr |
| Net Payables | Unspecified | -0.24% | ₹-1.99 Cr |
| Net Payables | Unspecified | -0.24% | ₹-1.99 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹45.01 | 29.48% | 17.51% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.18 | 29.48% | 17.51% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹528.09 | 27.60% | 17.14% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹366.90 | 27.60% | 17.14% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.15 | 27.32% | 16.58% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.40 | 27.32% | 16.58% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹41.50 | 28.38% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹24.21 | 28.38% | 16.48% | - |
| SBI Healthcare Opportunities Fund-growth |
₹457.42 | 26.27% | 15.91% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹288.15 | 26.27% | 15.91% | - |
Frequently Asked Questions
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
What is the current AUM of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
As of Tue Mar 31, 2026, Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw manages assets worth ₹858.9 crore
How has Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw performed recently?
- 3 Months: 10.24%
- 6 Months: 7.72%
What is the long-term performance of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
- 3 Years CAGR: 26.00%
- 5 Years CAGR: 14.68%
- Since Inception: 20.96%
What is the portfolio composition of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
Equity: 97.65%, Others: 2.35%.
Who manages Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw is managed by Dhaval Shah from Aditya Birla Sun Life Mutual Fund.
When was the last dividend declared by Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
Latest dividend was declared on 20 Feb 2026 at 14.10% of face value.
What is the market-cap allocation of Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw?
Large Cap: 33.86%, Mid Cap: 29.01%, Small Cap: 37.14%.
Which are the top companies Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 13.42% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.34% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.47% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.47% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.89% of the fund's portfolio
Which are the major sectors Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw focuses on?
- Healthcare – 946.95% of the fund's portfolio
- Unspecified – 21.24% of the fund's portfolio
- Industrials – 14.61% of the fund's portfolio
- Materials – 8.84% of the fund's portfolio
- Other – 8.36% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





